Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Schmid

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Oncology Research and Treatment|June 7, 2019
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic ModelPatrick Betschart, Christa Babst, Sabine Schmid, et al.
Journal of Radiation Research|December 23, 2004
Spatial and temporal variations of atmospheric 85Kr observed during 1995-2001 in Japan: estimation of atmospheric 85Kr inventory in the Northern HemisphereMichio Hirota, Kazuhiro Nemoto, Akira Wada, et al.
Cancer Management and Research|December 7, 2018
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatmentStefan Diem, Mirjam Fässler, Omar Hasan Ali, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trialPatrizia Froesch, Michael Mark, Sacha I Rothschild, et al.
Journal of Mood and Anxiety Disorders|July 14, 2025
Effects of TMS on anhedonia and suicidal ideation in treatment-resistant depression: Outcomes from the University of Minnesota Interventional Psychiatry ProgramA Irem Sonmez, Ryan Webler, Alyssa M Krueger, et al.
BMC Cancer|September 11, 2019
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival dataSabine Schmid, Dirk Klingbiel, Stefan Aebi, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2020
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohortSabine Schmid, Laetitia A Mauti, Alex Friedlaender, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancerNiklas Klümper, Jonas Saal, Fiamma Berner, et al.
Journal of Travel Medicine|July 31, 2020
Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1Silja Bühler, Veronika Katharina Jaeger, Gilles Eperon, et al.
Oncology Research and Treatment|December 23, 2014
Management of von hippel-lindau disease: an interdisciplinary reviewSabine Schmid, Silke Gillessen, Isabelle Binet, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Oncology Research and Treatment|June 7, 2019
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic ModelPatrick Betschart, Christa Babst, Sabine Schmid, et al.
Journal of Radiation Research|December 23, 2004
Spatial and temporal variations of atmospheric 85Kr observed during 1995-2001 in Japan: estimation of atmospheric 85Kr inventory in the Northern HemisphereMichio Hirota, Kazuhiro Nemoto, Akira Wada, et al.
Cancer Management and Research|December 7, 2018
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatmentStefan Diem, Mirjam Fässler, Omar Hasan Ali, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Binimetinib, pemetrexed and cisplatin, followed by maintenance of binimetinib and pemetrexed in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trialPatrizia Froesch, Michael Mark, Sacha I Rothschild, et al.
Journal of Mood and Anxiety Disorders|July 14, 2025
Effects of TMS on anhedonia and suicidal ideation in treatment-resistant depression: Outcomes from the University of Minnesota Interventional Psychiatry ProgramA Irem Sonmez, Ryan Webler, Alyssa M Krueger, et al.
BMC Cancer|September 11, 2019
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival dataSabine Schmid, Dirk Klingbiel, Stefan Aebi, et al.
Cancer Immunology, Immunotherapy : CII|April 21, 2020
Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohortSabine Schmid, Laetitia A Mauti, Alex Friedlaender, et al.
Journal for Immunotherapy of Cancer|March 16, 2022
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancerNiklas Klümper, Jonas Saal, Fiamma Berner, et al.
Journal of Travel Medicine|July 31, 2020
Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1Silja Bühler, Veronika Katharina Jaeger, Gilles Eperon, et al.
Oncology Research and Treatment|December 23, 2014
Management of von hippel-lindau disease: an interdisciplinary reviewSabine Schmid, Silke Gillessen, Isabelle Binet, et al.
Pageof 7